Abstract

Using the URL or DOI link below will
ensure access to this page indefinitely

Based on your IP address, your paper is being delivered by:

New York, USA

Processing request.

Illinois, USA

Processing request.

Brussels, Belgium

Processing request.

Seoul, Korea

Processing request.

California, USA

Processing request.

If you have any problems downloading this paper,please click on another Download Location above, or view our FAQFile name: SSRN-id2158351. ; Size: 236K

You will receive a perfect bound, 8.5 x 11 inch, black and white printed copy of this PDF document with a glossy color cover. Currently shipping to U.S. addresses only. Your order will ship within 3 business days. For more details, view our FAQ.

Quantity:Total Price = $9.99 plus shipping (U.S. Only)

If you have any problems with this purchase, please contact us for assistance by email: Support@SSRN.com or by phone: 877-SSRNHelp (877 777 6435) in the United States, or +1 585 442 8170 outside of the United States. We are open Monday through Friday between the hours of 8:30AM and 6:00PM, United States Eastern.

Prospects for Comparative Effectiveness Research Under Federal Health Reform

Comparative Effectiveness Research is a type of health services research that could possibly transform the health care sector of the United States. At least that is what many federal policy makers and third party payers are hoping as health care costs continue to rise at alarming rates. In 2009, national health expenditures grew four percent to $2.5 trillion, or $8,086 per person, and accounted for 17.6 percent of GDP. This increase in health care costs threatens the success of newly enacted health reform as well as existing public and private health insurance programs and plans. This paper describes federally sponsored comparative effectiveness research and policy. In addition to laying out aspirations and apprehensions about the use of comparative effectiveness research, the paper addresses the prospects for comparative effectiveness research as a successful strategy for bending the proverbial cost curve in health care expenditures.